Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.27 – $0.98
29% from low
Exchange
OTC Link
OS
JUSHI HLDGS INC CL B
No one on the platform currently holds JUSHF.
No tracked institution reports a position in JUSHF as of their last filing.
No one on the platform has traded JUSHF yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$JUSHF - Fair Value: Maintained at $1.50 per share, with no change between the prior and updated estimates. - Analysts have kept their $1.50 price target on Jushi Holdings unchanged, citing only modest tweaks to assumptions on discount rate, profit margin and future P/E that did not materially shift their valuation view. - Jushi Holdings submitted applications to the U.S. Drug Enforcement Administration for registration of certain state licensed medical marijuana operations under the new federal framework following the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act. (Source: Company announcement, Key Developments)
View on StockTwits ↗$JUSHF https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/otc-jush.f/jushi-holdings/3wz1txct-pennsylvania-and-virginia-reforms-will-unlock-new-market-opportunities-eo6n/updates/7-7-analysts-have-kept-their-dollar150-price-target-on-jushi-holding?utm_source=Braze&utm_medium=email&utm_campaign=CommunityDigest
View on StockTwits ↗$JUSHF BREAKING: Virginia's House just passed a budget bill that would legalize recreational cannabis sales, hours after it passed the full Senate. The proposal will now be sent to Governor Spanberger, who is expected to sign it into law.
View on StockTwits ↗$MSOS $CURLD Had a feeling Spanberger was going to right that wrong based on the tone of her responses to all the backlash. I think she was caught pretty far off guard with how much her approval rating tanked. VA legalization is huge, and right before the hearings. $JUSHF is supposed to be hands-down the biggest beneficiary. Whether that gets reflected in a $0.48/share cannabis stock is anyone's guess... https://www.marijuanamoment.net/virginia-lawmakers-and-governor-have-a-deal-on-bill-to-legalize-marijuana-sales-this-month/
View on StockTwits ↗$JUSHF Virginia lawmakers and Gov. Abigail Spanberger (D) have had "very fruitful" conversations about a compromise approach to legalizing recreational cannabis sales that could pass this month as part of budget legislation, a key lawmaker told Marijuana Moment. A spokesperson for the governor told Marijuana Moment that she "looks forward to moving this across the finish line together" with the sponsors of earlier cannabis commercialization legislation she vetoed.
View on StockTwits ↗$JUSHF Does anyone here believe MedMen will surface a comeback once the industry begins getting institutional capital? $MSOS
View on StockTwits ↗$JUSHF Virginia lawmakers & Gov. Abigail Spanberger have had "very fruitful" conversations about a compromise approach to legalizing recreational cannabis sales that could pass this month as part of budget legislation, a key lawmaker told Marijuana Moment.
View on StockTwits ↗$JUSHF Legislators looking to include cannabis rec in their next Bill. https://www.marijuanamoment.net/virginia-cannabis-commission-holds-first-hearing-following-governors-veto-of-bill-to-legalize-recreational-sales/
View on StockTwits ↗$JUSHF expected given sell off post kicking back bill. Still hurts. sorry VA citizens, you're governor lied to you
View on StockTwits ↗$JUSHF Still a ways to go it seems, but steps in the right direction carefully being planned out by leadership.
View on StockTwits ↗$JUSHF $MSOS. Updated thoughts. I continue to think that there is no other name in the top 10 MSOS names that has more leverage to S3 and markets transitioning to Adult Use than Jushi. Is there some risk to this view particularily AU in VA. Certainly there is, and that will be crystalized on or before May 22nd. Personally, I think odds still favour passage. I would put it at greater than 70%. Other better informed people have indicated likely higher. Regardless failure which would likely be more of a 1yr delay than outright failure would certainly be a negative but not a death blow. Strategically, assuming we get VA passed I expect JUSHI to outpreform over the next 12-18mths. However, I would caution that I can see a scenario where the first wave of money might go to disporportionally to the larger better known names. Regardless I would expect Justhi would preform well over the cycle and potential could also benefit from a preceived take over premium. I guess time will tell.
View on StockTwits ↗$JUSHF Nice to see a solid day. However, JUSH is still underpreforming for the week. I suspect it is just a function of people reaching for larger better known names. However given their outsized leverage to S3 and transition to adult use markets (VA and soon PA) relative to their market cap they should really outperform over time. When that shift happens is unclear but quite confident the will perform in the top quartile of the names in the sector over the next 6 to 12 months.
View on StockTwits ↗$JUSHF given PA and VA are at this point 100% medical markets Jushi must be something like 65-75% medical.
View on StockTwits ↗$JUSHF Rescheduling is a game changer for Jushi Holdings. 280E tax relief alone can dramatically improve cash flow and profitability—without any revenue growth. This is the kind of shift that can re-rate the entire sector.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.